On this page

Ticovac

Tick-Borne Encephalitis Vaccine

351(a) Standalone BLA

Overview

Source: Purple Book
Proprietary name
Ticovac
Proper name
Tick-Borne Encephalitis Vaccine
Licence type
351(a)
BLA number
125740
Applicant
Pfizer Ireland Pharmaceuticals Unlimited Company
Center
CBER
Presentations
2
First licensure
—

Presentations

Source: Purple Book
Every strength and presentation recorded in the Purple Book for this product.
Strength Dosage form Route Presentation Status Licensed
1.2UG/0.25ML Injection Intramuscular Pre-Filled Syringe Rx August 13, 2021
2.4UG/0.5ML Injection Intramuscular Pre-Filled Syringe Rx August 13, 2021

Sources for this page

Purple Book FDA Licence type, presentations, reference product, exclusivity